Filing Details

Accession Number:
0001493152-24-016062
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-04-26 08:30:35
Reporting Period:
2024-04-25
Accepted Time:
2024-04-26 08:30:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
318306 Abeona Therapeutics Inc. ABEO Pharmaceutical Preparations (2834) 830221517
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1715291 Walter Joseph Vazzano 6555 Carnegie Ave, 4Th Floor
Cleveland OH 44103
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-04-25 5,608 $3.14 233,868 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.13 to $3.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote.